BC-3C Cells
CAD$690.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | BC3c is a human bladder carcinoma cell line established from a surgical biopsy of an invasive solid transitional cell carcinoma derived from an adult female donor. The cell line was generated from primary tumor tissue through enzymatic dissociation and serial passaging in McCoy’s 5A medium supplemented with fetal calf serum. BC3c cells display an epithelial morphology with adherent growth and form cohesive colonies in vitro. Immunocytochemical characterization confirmed epithelial origin through expression of cytokeratins 8 and 19, while mesenchymal markers such as vimentin and fibroblast-associated antigens were absent. The cells do not express α-fetoprotein or carcinoembryonic antigen. Cytogenetic analysis demonstrated a near-triploid karyotype with multiple structural and numerical chromosomal abnormalities, consistent with genomic instability typical of invasive urothelial carcinoma. Molecular analysis did not detect activating mutations in H-ras codon 12 or K-ras codons 12 and 13, and no mutations were identified in examined hotspot codons of TP53. Furthermore, there was no accumulation of p53 protein detected by immunocytochemistry, suggesting the absence of common p53 stabilization events in this model. BC3c cells exhibit rapid in vitro proliferation, including growth under low-serum conditions, indicative of autocrine growth stimulation. Conditioned medium from BC3c cultures supports proliferation, supporting the presence of endogenous growth-promoting factors. |
|---|---|
| Organism | Human |
| Tissue | Urinary bladder |
| Disease | Bladder carcinoma |
| Synonyms | BC3c |
Characteristics
| Age | 82 years |
|---|---|
| Gender | Female |
| Ethnicity | Caucasian |
| Growth properties | Adherent |
Regulatory Data
| Citation | BC-3C (Cytion catalog number 305246) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_1958 |
Biomolecular Data
Handling
| Culture Medium | McCoys 5a, w: 3.0 g/L Glucose, w: stable Glutamine, w: 2.0 mM Sodium pyruvate, w: 2.2 g/L NaHCO3 (Cytion article number 820200a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS |
| Dissociation Reagent | Accutase 20 min 37°C |
| Doubling time | ~25-30 hours |
| Freeze medium | As a cryopreservation medium, we use complete growth medium + 10% DMSO for adequate post-thaw viability. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |